The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis

The management of rheumatoid arthritis (RA) is primarily based on the use of disease-modifying antirheumatic drugs (DMARDs), mainly comprising synthetic chemical compounds (that is, methotrexate or leflunomide) and biological agents (tumor necrosis factor inhibitors or abatacept). On the other hand,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cutolo, Maurizio, Spies, Cornelia M, Buttgereit, Frank, Paolino, Sabrina, Pizzorni, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249490/
https://www.ncbi.nlm.nih.gov/pubmed/25608624
http://dx.doi.org/10.1186/ar4685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249490/
https://www.ncbi.nlm.nih.gov/pubmed/25608624
http://dx.doi.org/10.1186/ar4685

Ejemplares similares